GlassScriptPhysician profile
Jameea Ward
NPI 1427721703
$1,727.18
in general payments reported to CMS, 2019-2025
18 companies · $451 in 2025
The $451 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $32.69 · 2022: $226 · 2023: $299 · 2024: $718 · 2025: $451.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,468.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,468.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $410.18 | 2021-2025 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $268.85 | 2023-2025 | Farxiga, Airsupra |
| Amgen INC. | $190.53 | 2023-2025 | Repatha, Repatha, Otezla |
| Cumberland Pharmaceuticals, INC. | $173.09 | 2022-2025 | Kristalose |
| Exact Sciences Corporation | $146.56 | 2024-2025 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $76.86 | 2022-2025 | Jardiance |
| Lilly USA, LLC | $73.46 | 2023-2024 | Mounjaro, Trulicity |
| Evoke Pharma, INC. | $62.76 | 2022-2023 | Gimoti |
| Bayer Healthcare Pharmaceuticals INC. | $59.40 | 2024-2025 | |
| Phathom Pharmaceuticals, INC. | $48.69 | 2023-2024 | Voquezna |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $44.75 | 2024-2025 | Xifaxan, Trulance |
| Alk-Abello, INC | $41.98 | 2024 | Grastek, Alternaria Tenuis, Odactra |
| Cranial Technologies, INC | $31.57 | 2023-2024 | Doc Band |
| Medtronic, INC. | $29.77 | 2022 | |
| Pfizer INC. | $24.00 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $17.57 | 2024 | Aptima, Thinprep 2000 Processor |
| Merck Sharp & Dohme LLC | $16.17 | 2024 | Capvaxive, Vaxelis, Gardasil |
| Genentech USA, INC. | $10.99 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jameea Ward listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.